Cargando…

MEG3 LncRNA from Exosomes Released from Cancer-Associated Fibroblasts Enhances Cisplatin Chemoresistance in SCLC via a MiR-15a-5p/CCNE1 Axis

PURPOSE: Long non-coding RNAs (lncRNAs) may act as oncogenes in small-cell lung cancer (SCLC). Exosomes containing lncRNAs released from cancer-associated fibroblasts (CAF) accelerate tumorigenesis and confer chemoresistance. This study aimed to explore the action mechanism of the CAF-derived lncRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yulu, Hao, Guijun, Zhuang, Mengqi, Lv, Huijuan, Liu, Chunhong, Su, Keli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860932/ https://www.ncbi.nlm.nih.gov/pubmed/35184425 http://dx.doi.org/10.3349/ymj.2022.63.3.229

Ejemplares similares

Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
por: Ren, Jing, et al.
Publicado: (2018)

CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance
por: Sapoznik, Stav, et al.
Publicado: (2017)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance: Understanding SCLC heterogeneity and plasticity in metastasis and chemoresistance
por: Jin, Yujuan, et al.
Publicado: (2023)

LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
por: Du, Ying, et al.
Publicado: (2022)

The Association of MEG3 lncRNA with Nuclear Speckles in Living Cells
por: Hasenson, Sarah E., et al.
Publicado: (2022)

A review on the role of MEG8 lncRNA in human disorders
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3
por: Liu, Yingnan, et al.
Publicado: (2021)

LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
por: Li, Zhi-hua, et al.
Publicado: (2020)

LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
por: Wang, Yanhua, et al.
Publicado: (2021)

Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023)

Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
por: Bao, Jiarong, et al.
Publicado: (2019)

Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3
por: Li, Xinyi, et al.
Publicado: (2018)

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2
por: Liang, Yuan, et al.
Publicado: (2020)

Se alleviates homocysteine-induced fibrosis in cardiac fibroblasts via downregulation of lncRNA MEG3
por: Li, Wei, et al.
Publicado: (2021)

APOE-mediated suppression of the lncRNA MEG3 protects human cardiovascular cells from chronic inflammation
por: Zhao, Hongkai, et al.
Publicado: (2023)

Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy
por: Pawar, Kamlesh, et al.
Publicado: (2016)

Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children
por: Zhuo, Zhen-Jian, et al.
Publicado: (2018)

LncRNA Meg3 protects endothelial function by regulating the DNA damage response
por: Shihabudeen Haider Ali, Mohamed Sham, et al.
Publicado: (2019)

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
por: Bayarmaa, Battseren, et al.
Publicado: (2019)

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)

Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway
por: Uroda, Tina, et al.
Publicado: (2019)

Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus
por: Zhang, Hailing
Publicado: (2019)

The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
por: Wang, Hao, et al.
Publicado: (2018)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs
por: Tong, Yusuo, et al.
Publicado: (2020)

Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer
por: Shi, Yuanyuan, et al.
Publicado: (2022)

Expression of lncRNA MEG3 in asthma with different phenotypes and its relationship with course of disease
por: Feng, Yan, et al.
Publicado: (2020)

lncRNA MEG8 is downregulated in osteoarthritis and regulates chondrocyte cell proliferation, apoptosis and inflammation
por: Xie, Wei, et al.
Publicado: (2021)

LncRNA MEG3-TRPV1 signaling regulates chronic inflammatory pain in rats
por: Peng, Jing-Wei, et al.
Publicado: (2022)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia
por: Ke, Shandong, et al.
Publicado: (2019)

LncRNA OXCT1-AS1 promotes the proliferation of non-small cell lung cancer cells by targeting the miR-195/CCNE1 axis
por: Wang, Dapeng, et al.
Publicado: (2022)

Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin
por: Zhang, Chao, et al.
Publicado: (2019)

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
por: Wang, Pei, et al.
Publicado: (2017)

Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis
por: Zhu, Zi-Jiang, et al.
Publicado: (2021)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56el990okji7ohnf9239gt4km1